CIK 0001829635 · <br>Emerging growth company
Transcode Therapeutics, Inc.
Sign in to watch- Ticker
- RNAZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811065054
- Phone
- 857-301-6857
- Business address
- 6 LIBERTY SQUARE, #2382, BOSTON, MA, 02109
- 8-K Event Results of operations
- SC 13D Stake Beneficial Ownership Report
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- EFFECT Other Notice of Effectiveness
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 8-K Event Delisting notice
- RW Other RW
- S-1/A Offering Registration Statement
- 8-K Event Regulation FD disclosure · Other events
- S-1 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
Page 13 of 17 · 324 filings